---
category: news
title: "NEC: harnessing artificial intelligence-powered drug development to provide tailored medicines"
excerpt: "Individualized cancer therapies represent the next step for cancer immunotherapy. NEC Corporation has developed cutting-edge artificial intelligence to predict patient-specific neoantigens to turn this promise into reality and extend the approach to infectious diseases."
publishedDateTime: 2022-04-11T16:38:00Z
originalUrl: "https://www.nature.com/articles/d43747-022-00109-2"
webUrl: "https://www.nature.com/articles/d43747-022-00109-2"
type: article
quality: 42
heat: 42
published: false

provider:
  name: Nature
  domain: nature.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://media.nature.com/lw1024/magazine-assets/d43747-022-00109-2/d43747-022-00109-2_20292782.png"
    width: 1024
    height: 524
    isCached: true

secured: "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;ko6CFsO4eDs73Le53SlBVA=="
---

